Clinical trial Recruiting at 1 site Observational

Automatic detection of breathlessness in adults on mechanical ventilation

Official title: Automatic Detection of Dyspnea in Mechanically Ventilated, Critically Ill Patients

Run by Hospital de Clinicas José de San Martín · NCT07205952 · Data updated 2026-11-12

This project will try to use ventilator pressure and flow signals to detect breathlessness in non-communicative adults recently intubated and receiving mechanical ventilation in the ICU.

More Dyspnea During Mechanical Ventilation trials

Quick facts

Study typeObservational
SexAll
Enrollment60 (estimated)
SponsorHospital de Clinicas José de San Martín
Academic / other
Locations1 site (Buenos Aires, Buenos Aires)
StatusRecruiting
StartedNovember 22, 2024
Main results expectedOctober 2025
Study endsOctober 2025
Registry record updatedOctober 3, 2025
Trial IDNCT07205952 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) who were endotracheally intubated within the past 24 hours, are non-communicative, and are expected to require at least 24 hours of mechanical ventilation.

Probably not a fit

Patients receiving continuous neuromuscular blockade, those ventilated on Airway Pressure Release Ventilation (APRV) mode, or patients who can reliably report symptoms are unlikely to benefit from this automated detection approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will enroll about 60 adult ICU patients who were endotracheally intubated within the previous 24 hours and are expected to need at least 24 hours of mechanical ventilation. Ventilator airway pressure and flow will be streamed into 131.1-second epochs for up to five days and a recursive algorithm will estimate inspiratory muscle pressure (Pmus) and calculate inspiratory effort time-pressure product (PmusPTP). Trained staff will collect MV-RDOS scores at least twice daily and time-match these subjective dyspnea ratings to the ventilator signal epochs to measure correlation and derive an ROC AUC threshold for PmusPTP equivalent to MV-RDOS > 2.6. Six supervised classifiers and a unanimity ensemble will be used to label discordant pairs, and ensemble-conflicting labels will be excluded from a secondary analysis.

Why it matters

Potential benefit: If successful, this work could provide a continuous, objective way to detect dyspnea at the bedside so clinicians can identify and treat breathlessness sooner.

How similar studies have gone: Prior physiologic and pilot studies using ventilator waveforms and machine learning have shown promise at estimating inspiratory effort, but continuous automated dyspnea detection in mechanically ventilated patients remains relatively novel and not yet widely validated.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* Adults of either sex (≥18 years)
* Endotracheally intubated in the past 24 hours.
* Expected to require ≥24 hours of mechanical ventilation.

Exclusion criteria:

* Continuous neuromuscular blockade.
* Ventilated on Airway Pressure Release Ventilation mode.

Where it's running

  • Hospital de Clínicas de la Universidad de Buenos Aires
    Buenos Aires, Buenos Aires, Argentina
    Recruiting

Study contacts

  • Principal investigator: Guillermo Gutierrez — The George Washington University School of Medicine and Health Sciences
  • Study coordinator: Guillermo Gutierrez, MD, PhD
  • Email: gutier@gwu.edu
  • Phone: 17035595843

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.